Walleye Capital
GBIO

Walleye Capital’s Generation Bio GBIO Stock Holding History

Walleye Capital’s Portfolio GBIO Stock Details GBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,880
Closed -$100K – 3339
2022
Q3 		$100K Buy
+1,880
New +$118K ﹤0.01% 2426
2022
Q1 		– Sell
-6,214
Closed -$440K – 2386
2021
Q4 		$440K Buy
+6,214
New +$1.08M 0.01% 1058

Other funds holding GBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Walleye Capital's GBIO Position: Q4 2022 in Review

Walleye Capital sold out of Generation Bio (GBIO) in Q4 2022, closing a stake of 1,880 shares — an estimated $100K sold.

Walleye Capital first reported a position in GBIO in Q4 2021 and held it in 2 quarters. The position peaked at $440K in Q4 2021. 95 funds tracked by Wall St. Rank hold GBIO as of Q4 2022.

  • Walleye Capital reported no remaining Generation Bio position as of Q4 2022 after selling out during the quarter.
  • Walleye Capital sold 1,880 Generation Bio shares in Q4 2022, an estimated $100K.
  • Walleye Capital first reported a position in Generation Bio in Q4 2021 and held it in 2 quarters.
  • Walleye Capital's Generation Bio position peaked at $440K in Q4 2021.
  • 95 funds tracked by Wall St. Rank held Generation Bio as of Q4 2022.

Based on Walleye Capital's 13F filing for Q4 2022, filed 14 Feb 2023.